Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport

被引:97
作者
Ozawa, K
Kondo, T
Hori, O
Kitao, Y
Stern, DM
Eisenmenger, W
Ogawa, S
Ohshima, T
机构
[1] Kanazawa Univ, Sch Med, Dept Neuroanat, Fac Med, Kanazawa, Ishikawa 9208640, Japan
[2] Japan Sci & Technol, CREST, Kawaguchi, Japan
[3] Kanazawa Univ, Fac Med, Dept Legal Med, Kanazawa, Ishikawa 9208640, Japan
[4] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY USA
[5] Univ Munich, Dept Legal Med, Munich, Germany
关键词
D O I
10.1172/JCI200111772
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Expression of angiogenic factors such as VEGF under conditions of hypoxia or other kinds of cell stress contributes to neovascularization during wound healing. The inducible endoplasmic reticulum chaperone oxygen-regulated protein 150 (ORP150) is expressed in human wounds along with VEGF. Colocalization of these two molecules was observed in macrophages in the neovasculature, suggesting a role of ORP150 in the promotion of angiogenesis. Local administration of ORP150 sense adenovirus to wounds of diabetic mice, a treatment that efficiently targeted this gene product to the macrophages of wound beds, increased VEGF antigen in wounds and accelerated repair and neovascularization. In cultured human macrophages, inhibition of ORP150 expression caused retention of VEGF antigen within the endoplasmic reticulum (ER), while overexpression of ORP150 promoted the secretion of VEGF into hypoxic culture supernatants, Taken together, these data suggest an important role for ORD150 in the setting of impaired wound repair and identify a key, inducible chaperone-like molecule in the ER. This novel facet of the angiogenic response may be amenable to therapeutic manipulation.
引用
收藏
页码:41 / 50
页数:10
相关论文
共 45 条
[1]  
Arroyo MVA, 1998, KIDNEY INT, V54, pS7
[2]   150-kDa oxygen-regulated protein (ORP150) functions as a novel molecular chaperone in MDCK cells [J].
Bando, Y ;
Ogawa, S ;
Yamauchi, A ;
Kuwabara, K ;
Ozawa, K ;
Hori, O ;
Yanagi, H ;
Tamatani, M ;
Tohyama, M .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2000, 278 (06) :C1172-C1182
[3]  
Berman ME, 1996, J IMMUNOL, V156, P1515
[4]  
Bondeson J, 1999, J IMMUNOL, V162, P2939
[5]  
BRETT J, 1993, AM J PATHOL, V143, P1699
[6]   EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) BY EPIDERMAL-KERATINOCYTES DURING WOUND-HEALING [J].
BROWN, LF ;
YEO, KT ;
BERSE, B ;
YEO, TK ;
SENGER, DR ;
DVORAK, HF ;
VANDEWATER, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1375-1379
[7]   STRUCTURAL REQUIREMENTS FOR DIMERIZATION, GLYCOSYLATION, SECRETION, AND BIOLOGICAL FUNCTION OF VPF/VEGF [J].
CLAFFEY, KP ;
SENGER, DR ;
SPIEGELMAN, BM .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1995, 1246 (01) :1-9
[8]   Role of ERAB/L-3-hydroxyacyl-coenzyme A dehydrogenase type II activity in Aβ-induced cytotoxicity [J].
Du Yan, S ;
Shi, YG ;
Zhu, AP ;
Fa, J ;
Zhu, HJ ;
Zhu, YC ;
Gibson, L ;
Stern, E ;
Collison, K ;
Al-Mohanna, F ;
Ogawa, S ;
Roher, A ;
Clarke, SG ;
Stern, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (04) :2145-2156
[9]   Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene [J].
Ferrara, N ;
CarverMoore, K ;
Chen, H ;
Dowd, M ;
Lu, L ;
OShea, KS ;
PowellBraxton, L ;
Hillan, KJ ;
Moore, MW .
NATURE, 1996, 380 (6573) :439-442
[10]   Efficient adenoviral infection with IκBα reveals that macrophage tumor necrosis factor α production in rheumatoid arthritis is NF-κB dependent [J].
Foxwell, B ;
Browne, K ;
Bondeson, J ;
Clarke, C ;
De Martin, R ;
Brennan, F ;
Feldmann, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) :8211-8215